Your browser doesn't support javascript.
loading
Self-adjuvanted mRNA vaccination in advanced prostate cancer patients: a first-in-man phase I/IIa study.
Kübler, Hubert; Scheel, Birgit; Gnad-Vogt, Ulrike; Miller, Kurt; Schultze-Seemann, Wolfgang; Vom Dorp, Frank; Parmiani, Giorgio; Hampel, Christian; Wedel, Steffen; Trojan, Lutz; Jocham, Dieter; Maurer, Tobias; Rippin, Gerd; Fotin-Mleczek, Mariola; von der Mülbe, Florian; Probst, Jochen; Hoerr, Ingmar; Kallen, Karl-Josef; Lander, Thomas; Stenzl, Arnulf.
Afiliação
  • Kübler H; Klinikum rechts der Isar der Technischen Universität München, Munich, Germany.
  • Scheel B; CureVac GmbH, Paul-Ehrlich-Str. 15, Tuebingen, 72076 Germany.
  • Gnad-Vogt U; CureVac GmbH, Paul-Ehrlich-Str. 15, Tuebingen, 72076 Germany.
  • Miller K; Charité University Hospital Berlin, Berlin, Germany.
  • Schultze-Seemann W; University Hospital Freiburg, Freiburg, Germany.
  • Vom Dorp F; Universitäty Hospital Essen, Essen, Germany.
  • Parmiani G; San Raffaele Scientific Institute, Milan, Italy.
  • Hampel C; University Hospital of the Johannes-Gutenberg-University Mainz, Mainz, Germany.
  • Wedel S; Ortenau Klinikum Offenburg-Gengenbach, Offenburg, Germany.
  • Trojan L; University Hospital Göttingen, Göttingen/University Hospital Mannheim, Mannheim, Germany.
  • Jocham D; University Hospital Schleswig-Holstein Campus Luebeck, Luebeck, Germany.
  • Maurer T; Klinikum rechts der Isar der Technischen Universität München, Munich, Germany.
  • Rippin G; Rippin-Consulting, Solingen, Germany.
  • Fotin-Mleczek M; CureVac GmbH, Paul-Ehrlich-Str. 15, Tuebingen, 72076 Germany.
  • von der Mülbe F; CureVac GmbH, Paul-Ehrlich-Str. 15, Tuebingen, 72076 Germany.
  • Probst J; CureVac GmbH, Paul-Ehrlich-Str. 15, Tuebingen, 72076 Germany.
  • Hoerr I; CureVac GmbH, Paul-Ehrlich-Str. 15, Tuebingen, 72076 Germany.
  • Kallen KJ; CureVac GmbH, Paul-Ehrlich-Str. 15, Tuebingen, 72076 Germany.
  • Lander T; CureVac GmbH, Paul-Ehrlich-Str. 15, Tuebingen, 72076 Germany.
  • Stenzl A; University Hospital Tuebingen, Tuebingen, Germany.
J Immunother Cancer ; 3: 26, 2015.
Article em En | MEDLINE | ID: mdl-26082837
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Alemanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Alemanha